Literature DB >> 9337442

Minocycline-induced lupus.

D K Farver1.   

Abstract

OBJECTIVE: To report a case of drug-induced lupus occurring 5 months after the initiation of minocycline therapy for acne. DATA SOURCE: Case report information was obtained from the physician, patient's family, and the medical record. MEDLINE and Index Medicus were searched to obtain relevant published literature from 1966 to 1996. CASE
SUMMARY: A 14-year-old white girl developed symptoms of myalgias, arthralgias, polyarthritis, and flushed face. The antinuclear antibody test was positive. Minocycline was discontinued and the patient's condition dramatically improved within 7 days.
CONCLUSIONS: Healthcare providers should recognize early common and unusual symptoms of minocycline-induced lupus in adolescents being treated for acne.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9337442     DOI: 10.1177/106002809703101009

Source DB:  PubMed          Journal:  Ann Pharmacother        ISSN: 1060-0280            Impact factor:   3.154


  4 in total

Review 1.  Benefits and risks of minocycline in rheumatoid arthritis.

Authors:  P Langevitz; A Livneh; I Bank; M Pras
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 2.  Cutaneous drug reactions in children: an update.

Authors:  Kara Heelan; Neil H Shear
Journal:  Paediatr Drugs       Date:  2013-12       Impact factor: 3.022

3.  Open-label add-on treatment trial of minocycline in fragile X syndrome.

Authors:  Carlo Paribello; Leeping Tao; Anthony Folino; Elizabeth Berry-Kravis; Michael Tranfaglia; Iryna M Ethell; Douglas W Ethell
Journal:  BMC Neurol       Date:  2010-10-11       Impact factor: 2.474

4.  Effects of 9-t-butyl doxycycline on the innate immune response to CNS ischemia-reperfusion injury.

Authors:  Nguyen Mai; Sara A Knowlden; Kathleen Miller-Rhodes; Viollandi Prifti; Max Sims; Mark Grier; Mark Nelson; Marc W Halterman
Journal:  Exp Mol Pathol       Date:  2020-12-29       Impact factor: 4.401

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.